Network Organisations

The European FH Patient Network actively working together to secure early identification and diagnosis of FH patients to prevent early cardiovascular disease.

Countries

The European FH Patient Network actively work together to secure early identification and diagnosis of FH patients to prevent early cardiovascular disease.

Network Organisations

Countries

who we are

FH Europe consists of multiple FH patient groups across Europe. By sharing information & best practice we aim to secure early identification and diagnosis.

More info

about fh

Familial Hypercholesterolaemia (FH) is an inherited genetic condition that leads to levels of cholesterol that are much higher than that of the general population.

More info

Our NETWORK

The network is made up of organisations and individuals that represent FH patient groups within their specific European country.

More info

Latest News

HEART BEAT NEWS – JULY 2021

HEART BEAT NEWS – JULY 2021

Read the July edition of FH Europe’s Heart Beat newsletter: In this edition: Watch the FH Roundtable discussion from EAS Congress: Next steps after the Global Call to Action on FH. Discover news from The Czech Republic about new alirocumab treatments available. Read...

HEART BEAT NEWS – JULY 2021

FH Europe Heart Beat News – June 2021

Right from the start, June has been very busy and packed with important updates. This month, we announce a joint statement from 12 leading CVD organisations to the EU. As the European Atherosclerosis Society hosted its annual conference, we bring the latest about patient online events in local languages by our members, Harteraad – The Netherlands, FHChol – Austria and CholCo E.V – Germany. You can also learn more about HEART UK’s Medical & Scientific Virtual Conference 2021

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design